REGENXBIO to Host Conference Call on November 8 to Discuss Third Quarter 2023 Financial Results and Recent Operational Highlights

Rhea-AI Summary

REGENXBIO Inc. will host a conference call on November 8, 2023, at 4:30 p.m. EST to discuss its financial results for the quarter ended September 30, 2023, and recent operational highlights. Listeners can register for the webcast and analysts can participate in the Q&A session. A replay of the webcast will be available on the company's investor website.

ROCKVILLE, Md., Nov. 1, 2023 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Wednesday, November 8, 2023, at 4:30 p.m. EST to discuss its financial results for the quarter ended September 30, 2023, and recent operational highlights.

Listeners can register for the webcast via this link. Analysts wishing to participate in the question and answer session should use this link. A replay of the webcast will be available via the company's investor website approximately two hours after the call's conclusion. Those who plan on participating are advised to join 15 minutes prior to the start time.

About REGENXBIO Inc.

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO's NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8 and AAV9. REGENXBIO and its third-party NAV Technology Platform Licensees are applying the NAV Technology Platform in the development of a broad pipeline of candidates, including late-stage and commercial programs, in multiple therapeutic areas. REGENXBIO is committed to a "5x'25" strategy to progress five AAV Therapeutics from our internal pipeline and licensed programs into pivotal-stage or commercial products by 2025.

Contacts:

Dana Cormack
Corporate Communications
dcormack@regenxbio.com 

Investors:
Chris Brinzey, ICR Westwicke
339-970-2843
chris.brinzey@westwicke.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/regenxbio-to-host-conference-call-on-november-8-to-discuss-third-quarter-2023-financial-results-and-recent-operational-highlights-301973778.html

SOURCE REGENXBIO Inc.

FAQ

When will REGENXBIO Inc. host a conference call?

REGENXBIO Inc. will host a conference call on November 8, 2023.

What will be discussed during the conference call?

The conference call will discuss REGENXBIO Inc.'s financial results for the quarter ended September 30, 2023, and recent operational highlights.

How can listeners register for the webcast?

Listeners can register for the webcast via the provided link.

How can analysts participate in the question and answer session?

Analysts can participate in the question and answer session by using the provided link.

Will there be a replay of the webcast?

Yes, a replay of the webcast will be available on the company's investor website approximately two hours after the call's conclusion.

What is the recommended time to join the conference call?

Participants are advised to join 15 minutes prior to the start time of the conference call.